We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

257 hedge funds and large institutions have $2.9B invested in Pacira BioSciences in 2020 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 92 increasing their positions, 84 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 31

13% more capital invested

Capital invested by funds: $2.56B → $2.9B (+$340M)

4% more funds holding

Funds holding: 248 → 257 (+9)

10% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 84

2.73% less ownership

Funds ownership: 115.66% → 112.93% (-2.7%)

29% less funds holding in top 10

Funds holding in top 10: 7 → 5 (-2)

59% less call options, than puts

Call options by funds: $2.95M | Put options by funds: $7.13M

Holders
257
Holders Change
+9
Holders Change %
+3.63%
% of All Funds
5.19%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.1%
New
42
Increased
92
Reduced
84
Closed
31
Calls
$2.95M
Puts
$7.13M
Net Calls
-$4.18M
Net Calls Change
-$820K

Top Buyers

Rank Fund Capital Flow
1
NPIC
Neumeier Poma Investment Counsel
California
+$25.1M
2
Macquarie Group
Macquarie Group
Australia
+$24.4M
3
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$17.4M
4
Wells Fargo
Wells Fargo
California
+$17.3M
5
SCM
Spyglass Capital Management
California
+$16.4M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$27M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$26.1M
3
HM
HealthCor Management
New York
-$21.3M
4
BlackRock
BlackRock
New York
-$21M
5
WP
Woodline Partners
California
-$10.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
ASN
251
Advisory Services Network
Georgia
$2K +$2.32K +40 New
BWM
252
BerganKDV Wealth Management
Minnesota
$1K – – –
JCM
253
Jacobi Capital Management
Pennsylvania
$1K – – –
BWA
254
BDO Wealth Advisors
Florida
$1K +$523 +9 New
FCA
255
FinTrust Capital Advisors
South Carolina
$41 -$47.2K -812 -55%
HM
256
HealthCor Management
New York
– -$21.3M -405,040 Closed
WP
257
Woodline Partners
California
– -$10.5M -200,720 Closed
EP
258
Eversept Partners
New York
– -$6.96M -132,655 Closed
Assenagon Asset Management
259
Assenagon Asset Management
Luxembourg
– -$3.84M -73,202 Closed
PP
260
PDT Partners
New York
– -$3.66M -69,713 Closed
PM
261
Prosight Management
Texas
– -$2.89M -55,000 Closed
WCM
262
Weld Capital Management
New York
– -$1.97M -37,507 Closed
DC
263
Diametric Capital
Massachusetts
– -$950K -18,110 Closed
PCM
264
Prelude Capital Management
New York
– -$811K -15,447 Closed
Qube Research & Technologies (QRT)
265
Qube Research & Technologies (QRT)
United Kingdom
– -$752K -14,329 Closed
Grantham, Mayo, Van Otterloo & Co (GMO)
266
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
– -$750K -14,300 Closed
Bessemer Group
267
Bessemer Group
New Jersey
– -$666K -12,700 Closed
RB
268
Rodgers Brothers
Pennsylvania
– -$542K -10,325 Closed
TCM
269
Teza Capital Management
Illinois
– -$421K -8,027 Closed
SEC
270
Seven Eight Capital
New York
– -$394K -7,500 Closed
SFM
271
Systematic Financial Management
New Jersey
– -$374K -7,125 Closed
BFM
272
Boothbay Fund Management
New York
– -$373K -7,110 Closed
JWS
273
Juncture Wealth Strategies
Arizona
– -$371K -7,066 Closed
ECM
274
Everence Capital Management
Indiana
– -$303K -6,900 Closed
SAM
275
Sectoral Asset Management
Quebec, Canada
– -$331K -6,300 Closed
8 9 10
11
12

PCRX Hedge Fund Activity: Q3 2020 in Review

257 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q3 2020, worth a combined $2.9B — up 13% from $2.56B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new PCRX positions and 31 closed out — a net gain of 11 holders — while 92 added to existing stakes and 84 trimmed.

The largest buyer was Neumeier Poma Investment Counsel, opening a new position worth an estimated $25.1M. The largest seller was Deerfield Management, cutting an estimated $27M.

  • 257 institutional investors held Pacira BioSciences (PCRX) as of Q3 2020, up from 248 in Q2 2020.
  • Funds reported $2.9B of Pacira BioSciences stock for Q3 2020, up 13% quarter-over-quarter.
  • 42 funds opened new Pacira BioSciences positions in Q3 2020 and 31 closed out, a net change of +11 holders.
  • The largest Pacira BioSciences buyer in Q3 2020 was Neumeier Poma Investment Counsel, an estimated $25.1M added.
  • The largest Pacira BioSciences seller in Q3 2020 was Deerfield Management, an estimated $27M sold.

Based on aggregated 13F filings for Q3 2020.